1-Benzyl-3-(tert-butyl)-1H-pyrazole-5-carboxylic acid
2-((2-(1-Fluorocyclopropyl)-4-(4-(2-methoxyphenyl)piperidin-1-yl)quinazolin-6-yl)(methyl)amino)ethan-1-ol
2-(1,3-Dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-isopropyl-N-(isopropylcarbamoyl)acetamide
(2S,3S)-2-Amino-3-methyl-N-(2-morpholinoethyl)pentanamide dihydrochloride
2-Cyclopropyl-6,7-dimethoxy-4-(4-(2-methoxyphenyl)piperazin-1-yl)quinazoline
[D-Trp11]-Neurotensin
BVFP
Neurotensin(8-13) 3TFA(60482-95-3(free base))
SORT-PGRN interaction inhibitor 3
Pd 90780
VGD071
L-Arginyl-L-arginyl-L-prolyl-L-tyrosyl-L-isoleucyl-L-leucine
Sortilin antagonist 1
((7-Hydroxy-4-methyl-2-oxo-2H-chromen-8-yl)methyl)-L-leucine
(2-(5-((4-Methylphenyl)sulfonamido)-3-(2,2,2-trifluoroacetyl)-1H-indol-1-yl)acetyl)-L-leucine
Latozinemab
